Prediction of viral loads for diagnosis of Hepatitis C infection in human plasma samples using Raman spectroscopy coupled with partial least squares regression analysis

Abstract

International audienceRaman spectroscopy has been used to identify the biochemical changes associated with the presence of the Hepatitis C virus (HCV) in infected human blood plasma samples as compared with healthy samples, as control. The aim of the study was to establish the Raman spectral markers of hepatitis infection, which could be used for diagnostic purposes. Moreover, multivariate data analysis techniques, including Principal Component Analysis (PCA), coupled with Linear Discriminant Analysis (LDA), and Partial Least Square Regression (PLSR) are employed to further demonstrate the diagnostic capability of the technique. The PLSR model is developed to predict the viral loads of the HCV infected plasma on the basis of the biochemical changes caused by the viral infection.Specific Raman spectral features are observed in the mean spectra of HCV plasma samples which are not observed in the control mean spectra. PCA differentiated the ‘normal’ and ‘HCV’ groups of the Raman spectra and PCA-LDA was employed to increase the efficiency of prediction of the presence of HCV infection, resulting in a sensitivity and specificity 98.8% and 98.6%, with corresponding Positive Predictive Value of 99.2%, and Negative Predictive Value of 98%. PLSR modelling was found to be 99% accurate in predicting the actual viral loads of the HCV samples, as determined clinically using the Polymerase Chain Reaction (PCR) technique, on the basis of the Raman spectral changes caused by the virus during the process of the development of Hepatitis C

Clinical applications of infrared and Raman spectroscopy: state of play and future challenges

“…Furthermore, fractionation of human serum by centrifugal filtration has been demonstrated to improve the quantitative analysis of low molecular weight biomarkers using ATR-IR spectroscopy, for the case of the variation of glucose levels in patient samples, such that it is comparable to currently employed clinical analysis techniques [144] and quantification of glycine to a level 50 times lower than when using whole human serum. Raman spectroscopy has similarly been demonstrated to accurately predict Hepatitis C viral loads in dried patient plasma samples [145], although the inherently higher spatial resolution of Raman microscopy renders it less favourable for integrating measurements over an inhomogeneous, dried deposit. Ultimately, in order to enable clinical translation there needs to be a focus on large population studies and procedural and instrumental standardisation to enable regulatory requirements to be met [146] Figure 7: ATR-FTIR Serum dilution study of dried drops.…”

Raman spectral analysis for rapid screening of dengue infection

“…Recently, viral infections such as human papilloma (HPV), Hepatitis C (HCV), dengue virus and many other diseases have been successfully monitored by Raman spectroscopy [29][30][31][32]. Khan et al.…”

In-vivo Raman spectroscopy: from basics to applications

“…136 Ex-vivo Raman-based diagnostics of asthma and hepatitis was investigated by analyzing serum and blood plasma samples. 137,138 Ulcerative colitis (UC) and Crohn's disease are two distinct types of IBD. The ability to endoscopically, pathologically, and radiologically diagnose and analyze the disease severity still needs improvement.…”